Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence of PEG coating on the particle size, drug release rate and phagocytic uptake
Introduction
It is well known that changing appropriately some physicochemical properties of polymeric nanoparticles, such as size and surface characteristics, it is possible to modulate their biodistribution parameters.
In the design of a colloidal drug delivery system, which can give a large biodistribution of the drug and can allow the reaching of particular sites, different from reticuloendothelial cells, it is necessary to avoid the removal of drug-loaded nanoparticles from blood by endocytic uptake of Kupfer cells or other phagocytic cell populations within the mononuclear phagocyte system (MPS) [1].
In case of polymeric drug carriers, constituted by polyalkylcyanoacrylate nanoparticles, to prevent this uptake it has been suggested to prepare very small nanoparticles [2], [3] or modify the surface of particulate carrier by more hydrophilic polymers avoiding opsonins adsorption on particles surface that makes them recognizable to the macrophages of the MPS [4], [5]. Polyethyleneglycol (PEG) is one of the most investigated hydrophilic polymers, able to modify the surface of particulate carriers [6], [7], [8]. PEG is fixed on particle surface by adsorption or covalent binding [9].
The results of recent studies show that nanoparticles prepared by emulsion polymerization of alkylcyanoacrylate in the presence of PEG represent potential stealth rapidly biodegradable carriers, possibly able to avoid MPS recognition in vivo [10], [11], [12], [13], [14].
The first purpose of this work was to prepare amoxicillin-loaded polyethylcyanoacrylate (PECA) nanoparticles in the presence and in the absence of PEG and to study the influence of PEG coating at different molecular weights on the particle size, zeta potential, loading capacity, rate of amoxicillin release from nanoparticles in some simulated biological fluids and phagocytic uptake, in view of a possible use of this colloidal carrier for controlled intravenous drug delivery and targeting.
Polyalkylcyanoacrylate nanoparticles have been also studied as oral drug carriers to overcome problems of administration of drugs that are unstable in the gastrointestinal tract or are inadequately adsorbed [15], [16], [17].
For example, the treatment of H. pylori infection in peptic ulcer disease usually requires a triple therapy that includes antibiotic, antibacterial and proton pump inhibitors. Unfortunately, infact, when administred in vivo, no single antibiotic is effective in eradication of H. pylori [18], [19].
The failure of a single antibiotic therapy could be due to poor stability of the drug in the acidic pH of the stomach, poor permeability of the antibiotics across the mucus layer, or due to the availability of sub-therapeutic antibiotic concentrations at the infection site after oral administration in a conventional capsule or tablet dosage form.
To overcome some of these problems, the preparation of an antibiotic delivery system which is able to localize the drug at infection site to achieve bactericidal concentrations, would be desirable [20], [21].
Taking into account the mucoadhesive properties of polyalkylcyanoacrylate nanoparticles [22] and the activity of the amoxicillin versus H. pylori [23], [24], the second purpose of this work was to study the colloidal drug delivery system obtained in our laboratory in order to evaluate its eventual peroral administration for the treatment of diseases caused by H. pylori.
Section snippets
Chemicals
Ethyl-2-cyanoacrylate (ECA) used as the monomer for polymerization, was obtained from Sigma Chemical Company (St. Louis, MO, USA).
PEG 600, 2000 and 4000 and Pluronic F68 were obtained from Fluka (Buchs, Switzerland).
Amoxicillin and urease type III from beans (16.0 U/g solid) were obtained from Sigma Chemical Company (St. Louis, MO, USA).
Water (HPLC grade) was used. All other chemicals were of analytical grade.
Preparation of amoxicillin-loaded nanoparticles
Amoxicillin-loaded nanoparticles were easily prepared by emulsion polymerization of
Results and discussion
Amoxicillin loaded PECA nanoparticles show a drug encapsulation capacity and a particle size distribution that can be successfully exploited for the formulation of colloidal pharmaceutical systems.
PECA nanoparticles were easily prepared by emulsion polymerization of ethylcyanoacrylate, using Pluronic F68 as surfactant, in the absence and in the presence of PEG at different molecular weights. Amoxicillin was solubilized in the polymerization medium, which is composed of aqueous solution
Conclusions
The present paper describes the experimental conditions for preparing amoxicillin loaded polyethylcyanoacrylate (PECA) nanoparticles in the presence and in the absence of polyethyleneglycol (PEG) at different molecular weights. It was observed that the PEG added in polymerization medium during the nanoparticle preparation, influences particle size, zeta potential, drug loading capacity, drug release rate and phagocytic uptake from murine macrophages.
Drug release studies at pH 7.4 and in human
Acknowledgments
This paper was financially supported by MURST grants.
References (30)
- et al.
Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles
J Colloid Interface Sci
(1985) - et al.
New method for the preparation of cyanoacrylic nanoparticles with improved colloidal properties
J Pharm Sci
(1989) - et al.
Stealth MePEG-PLA nanoparticles avoid uptake by the mononuclear phagocyte system
J Pharm Sci
(1995) “Stealth” corona-core nanoparticles surface modified by polyethylene glycol (PEG)influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption
Colloids Surf B
(2000)Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles
Biomaterials
(1999)- et al.
Disposition kinetics and oral bioavailability of vincamine-loaded polyalkylcyanoacrylate nanoparticles
J Pharm Sci
(1986) Peroral administration of nanoparticles
Adv Drug Del Rev
(1991)- et al.
Preparation, characterization and in vitro antimicrobial activity of ampicillin-loaded polyethylcyanoacrylate nanoparticles
Biomaterials
(1998) - et al.
Ten-day triple therapy with ranitidine, bismuth citrate, amoxicillin and clarithromycin in eradicating Helicobacter pylori
Am J Gastroenterol
(1999) - et al.
Effect of various poloxamer coatings on in vitro adhesion of isohexylcyanoacrylate nanospheres to rat ileal segments under liquid flow
Int J Pharm
(1992)
Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infectionresults of a prospective randomized open study
Am J Gastroenterol
Steric stabilization of nanoparticlesSize and surface properties
Int J Pharm
Phagocytic uptake of fluorescent stealth and non stealth solid lipid nanoparticles
Int J Pharm
Preparation and characterization of solid lipid nanospheres containing paclitaxel
Eur J Pharm Sci
Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles
Int J Pharm
Cited by (180)
Ultrasound-assisted encapsulation of ginger (Zingiber officinale) oil in gum arabic and its controlled release study
2023, Chemical Engineering and Processing - Process IntensificationCan histamine cause an enhancement of the cellular uptake and cytotoxicity of doxorubicin-loaded polylactide nanoparticles?
2023, European Journal of Pharmaceutical SciencesAdvancement and future perspectives on ampicillin-loaded antimicrobial polymers- A review
2023, Journal of Drug Delivery Science and TechnologyIn situ encapsulation of biologically active ingredients into polymer particles by polymerization in dispersed media
2023, Progress in Polymer ScienceCitation Excerpt :It can indeed modify the surface hydrophilicity and stability of the NPs, and can impart biologically relevant properties to the NPs (e.g., stealthiness, enhanced cellular uptake, opportunity for surface functionalization). It can also represent a second diffusion barrier in case of drug release [58,59]. Both direct and inverse emulsion polymerization can be considered for NP synthesis.
Cellulose-based activated carbon/layered double hydroxide for efficient removal of Clarithromycin residues and efficient role in the treatment of stomach ulcers and acidity problems
2022, International Journal of Biological Macromolecules